Eli Lilly (LLY) reportedly in advanced talks to acquire US cancer biotech Co. Scorpion Therapeutics for up to USD 2.5bln, according to FT
- As part of the proposed terms, LLY would pay Scorpion Therapeutics USD 1bln upfront followed by up to USD 1.5bkn at a later date if certain performance milestones are met.
10 Jan 2025 - 18:28- Forex- Source: FT
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts